Xie, Ruilian, Department of Oncology, The First Affiliated Hospital of Gannan Medical University, China
-
Vol 5, No 2.1: Special Issue - Research Progress in Immunotherapy in China (Published) - Original Research Article
Combining PD-1/PD-L1 inhibitor and PARP inhibitor: a new perspective on the treatment of triple negative breast cancer
Abstract PDF